London Daily

Focus on the big picture.
Tuesday, Jul 15, 2025

Britain is certainly not leading the fight against Covid-19

Britain is certainly not leading the fight against Covid-19

We are not in a race against each other, only coronavirus and the havoc it can wreak

Pfizer will start shipping the Covid vaccine it developed with German group BioNTech to the UK next week after its Medicines and Healthcare products Regulatory Agency approved its use on Wednesday.

The news sparked some very bizarre reactions.

On the one side, there was the by now usual jingoistic nonsense from certain UK quarters about Britain leading the fight against this global pandemic. Presumably simply ordering a product developed in Germany by a German and a US company and manufactured in Belgium constitutes British leadership these days.

On the other side, there was a crescendo of “how come we don’t have it yet?”

Both positions miss the point entirely. If the pandemic – note that word, it means an epidemic that is global, or at least international – has taught us anything, it is how mutually interdependent countries are in terms of travel, economics and health.

This is a new vaccine – in the case of the Pfizer/BioNTech one, an entirely new way of developing a vaccine. It has been developed at a pace that, before this pandemic, would have been considered impossible.

Safety


Public confidence in its ability to do its job effectively and safely is essential.

It is going to take several vaccines and many months, possibly years in some parts of the world, before Covid-19 is consigned to history, or at least considered routinely manageable.

Even in Britain, amid the celebration, it was clear listening to medical commentators that there is no certainty even now about the precise logistics for administering this first vaccine. Plans are being made on the hoof.

There is still much we have to learn. Full long-term safety and immunity data are not yet available. And what is available has been with regulators only for a short time. The formal application by Pfizer – and another vaccine maker, Moderna – for emergency authorisation in Europe and in the United States was made only this week.

We are not racing each other, only the virus and the havoc it can wreak on health, on the economy and on society. A bit of perspective would not go amiss.

Newsletter

Related Articles

0:00
0:00
Close
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Defends Attorney General Pam Bondi Amid Epstein Memo Backlash
Renault Shares Drop as CEO Luca de Meo Announces Departure Amid Reports of Move to Kering
Senior Aides for King Charles and Prince Harry Hold Secret Peace Summit
Anti‑Semitism ‘Normalised’ in Middle‑Class Britain, Says Commission Co‑Chair
King Charles Meets David Beckham at Chelsea Flower Show
If the Department is Really About Justice: Ghislaine Maxwell Should Be Freed Now
NYC Candidate Zohran Mamdani’s ‘Antifada’ Remarks Spark National Debate on Political Language and Economic Policy
President Trump Visits Flood-Ravaged Texas, Praises Community Strength and First Responders
From Mystery to Meltdown, Crisis Within the Trump Administration: Epstein Files Ignite A Deepening Rift at the Highest Levels of Government Reveals Chaos, Leaks, and Growing MAGA Backlash
Trump Slams Putin Over War Death Toll, Teases Major Russia Announcement
Reparations argument crushed
Rainmaker CEO Says Cloud Seeding Paused Before Deadly Texas Floods
A 92-year-old woman, who felt she doesn't belong in a nursing home, escaped the death-camp by climbing a gate nearly 8 ft tall
French Journalist Acquitted in Controversial Case Involving Brigitte Macron
Elon Musk’s xAI Targets $200 Billion Valuation in New Fundraising Round
Kraft Heinz Considers Splitting Off Grocery Division Amid Strategic Review
Trump Proposes Supplying Arms to Ukraine Through NATO Allies
EU Proposes New Tax on Large Companies to Boost Budget
Trump Imposes 35% Tariffs on Canadian Imports Amid Trade Tensions
Junior Doctors in the UK Prepare for Five-Day Strike Over Pay Disputes
US Opens First Rare Earth Mine in Over 70 Years in Wyoming
Kurdistan Workers Party Takes Symbolic Step Towards Peace in Northern Iraq
Bitcoin Reaches New Milestone of $116,000
Biden’s Doctor Pleads the Fifth to Avoid Self-Incrimination on President’s Medical Fitness
Grok Chatbot Faces International Backlash for Antisemitic Content
Severe Heatwave Claims 2,300 Lives Across Europe
NVIDIA Achieves Historic Milestone as First Company Valued at $4 Trillion
Declining Beer Consumption Signals Cultural Shift in Germany
Linda Yaccarino Steps Down as CEO of X After Two Years
×